EUVIMEDEUVIMED entdecken
Open Access

Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non–Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series

Ezra Bernstein iD, Jia Luo iD, Kaiwen Wang iD, Marcelo V Negrao iD, Pasi A Jänne iD, Joshua K Sabari iD

JCO Precision Oncology · 2024-02 · (8)

DOI: 10.1200/po.23.00447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2024-02. Verfasst von Ezra Bernstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Langone Department of Internal Medicine, New York University, New York, NY. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Piperazines, Pyrimidines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPiperazinesPyrimidinesHumansProto-Oncogene Proteins p21(ras)Acetonitriles

Substanzen

adagrasibProto-Oncogene Proteins p21(ras)AcetonitrilesKRAS protein, humanPiperazinesPyrimidines

Autor:innen und Institutionen

  • Langone Department of Internal Medicine, New York University, New York, NY.
  • Lowe Center for Thoracic Oncology, Dana-Faber Cancer Institute, Boston, MA.
  • Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Perlmutter Cancer Center, New York University Langone Health, New York, NY.

ORCID-Profile: Ezra Bernstein, Jia Luo, Kaiwen Wang, Marcelo V Negrao, Pasi A Jänne, Joshua K Sabari

Zitieren

APA

Bernstein, E., Luo, J., Wang, K., Negrao, M. V., Jänne, P. A., & Sabari, J. K. (2024). Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non–Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series. JCO Precision Oncology. https://doi.org/10.1200/po.23.00447

Vancouver

Bernstein E, Luo J, Wang K, Negrao MV, Jänne PA, Sabari JK. Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non–Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series. JCO Precision Oncology. 2024. doi:10.1200/po.23.00447

BibTeX
@article{Bernstein2024,
  author = {Bernstein, Ezra and Luo, Jia and Wang, Kaiwen and Negrao, Marcelo V and Jänne, Pasi A and Sabari, Joshua K},
  title = {Safety and Intracranial Activity of Adagrasib in Patients With KRAS G12C -Mutated Non–Small-Cell Lung Cancer and Untreated CNS Metastases in the KRYSTAL-1 Trial: A Case Series},
  journal = {JCO Precision Oncology},
  year = {2024},
  number = {8},
  doi = {10.1200/po.23.00447}
}
Kostenlos starten →